HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Multiple TKIs for first-line CML treatment ‘a mixed blessing’
-
- Bevacizumab plus lomustine improved outcomes in recurrent glioblastoma
- Mary-Claire King, PhD, receives Lasker medical science award
- Not again … but I thought the government and Pharma said the problem was fixed? Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- CASTLE: Cancer of the thyroid showing thymus-like differentiation Stephanie L. Lee, MD, PhD, ECNU
- PTEN-mutated Cowden disease increased risk for second malignant neoplasms
- Trametinib–dabrafenib combination extended PFS in BRAF-mutated melanoma
- Dabrafenib improved quality of life in patients with metastatic melanoma
- Lenalidomide active in recurrent ovarian cancer
-
- Lexaptepid shows promise for anemia of inflammation treatment
- Bevacizumab appears tolerable in cutaneous melanoma
- Docetaxel plus nintedanib effective second-line therapy for NSCLC
- Laparoscopic colorectal cancer surgery reduced length of hospital stay
- Lung cancer screening of Medicare-eligible patients associated with greater benefits, risks
- BRCA2 mutation associated with shorter survival in screen-detected prostate cancer
- Masitinib superior to sunitinib in advanced GIST
- Persistently negative D-dimers associated with low VTE recurrence
-
- t(14;18) translocation predicted follicular lymphoma development
- Tigecycline plus piperacillin-tazobactam shows promise for febrile neutropenia
- Malignant bowel obstruction palliative surgery linked to complications, mortality
- Ado-trastuzumab emtansine extended PFS in pretreated HER-2–positive breast cancer
- At-risk girls least likely to be offered HPV vaccine
- Cancer screenings common among those with shortest life expectancies
- Female sex associated with improved survival in HCC
- Flexible sigmoidoscopy screening reduced colorectal cancer incidence, mortality
-
- Multidisciplinary approach may better detect, treat depression among patients with cancer
- Researchers identify risk factors for soft tissue necrosis in OSCC
- Surgery improved outcomes in advanced laryngeal cancer
- Volasertib plus cytarabine extended survival in AML
- White blood cell recovery predicted OS, PFS after HCT
- Delayed cord clamping did not affect long-term iron status, neurodevelopment in infants
- Higher BMI increased risk for 10 common cancers
- Contralateral prophylactic mastectomy often used unnecessarily
-
- AACR presents research award
- Cancer center names BMT director
- Cancer center names director of BMT
- Nursing assistant receives award
- UPCI appoints program co-director
- 'Conjectural statement' could cause confusion about 340B program
- Addition of chemotherapy to radiation failed to improve outcomes in esophageal cancer
- BCT increasingly used, but barriers persist
-
- Margin status not linked to recurrence, survival in DCIS
- Veliparib active in BRCA-mutated breast cancer
- Adjuvant chemotherapy extended OS, DFS in luminal B breast cancer
- Aspirin, NSAIDs reduced risk for aggressive prostate cancer
- Crizotinib shows promise in ROS1-rearranged advanced NSCLC
- High-dose radiation plus long-term ADT extended survival in prostate cancer
- Novel vaccine benefitted high-risk patients with HER-2 overexpression
- Obesity, inflammation during adolescence increased colorectal cancer later in life
-
- Patients with advanced pancreatic NET achieved 44-month OS with Afinitor
- Pertuzumab conferred ‘unprecedented’ OS benefit in HER-2–positive metastatic breast cancer
- Radiation may replace axillary lymph node dissection after SLNB-detected N1 disease
- Rivaroxaban reduced VTE recurrence, major bleeding in patients with cancer
- Surgical excision may be avoidable for classic lobular neoplasia
- Breast reconstruction complications higher among women who underwent bilateral mastectomy
- PET/MR improved detection of metastases in breast cancer
- Post-progression data rarely reported in phase 3 metastatic breast cancer trials
-